IMR Press / FBE / Volume 1 / Issue 1 / DOI: 10.2741/E31

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.

Molecular therapeutics of cancer by means of electroporation-based transfer of siRNAs and EBV-based expression vectors
Show Less
1 Department of Microbiology, Kyoto Prefectural University of Medicine, Kyoto, Japan
Academic Editor:Katsumi Kitagawa
Front. Biosci. (Elite Ed) 2009, 1(1), 316–331;
Published: 1 June 2009
(This article belongs to the Special Issue Kinetochore and spindle checkpoint)

A variety of gene transfer technologies have been devised as tools for functional analysis of genes as well as gene therapy and regenerative medicine. Electroporation enables efficient genetic transfection in vivo into various organs as well as tumors without the aid of any infectious viral vector, and has been applied to preclinical nonviral gene therapy approaches. The efficacies of transfection and expression can be further elevated when the electroporation procedure was used to deliver Epstein-Barr virus (EBV)-based plasmid vectors that have characteristic artificial chromosome-like functions. Electroporation also facilitates delivery of synthetic short interfering RNA (siRNA) into some organs and tumors, potentially providing feasible strategies of RNAi-based molecular targeting therapy against various diseases including malignancies. 

Back to top